ALTAMURA, CONCETTA
 Distribuzione geografica
Continente #
NA - Nord America 2.549
AS - Asia 1.285
EU - Europa 1.177
SA - Sud America 362
Continente sconosciuto - Info sul continente non disponibili 235
AF - Africa 75
OC - Oceania 3
Totale 5.686
Nazione #
US - Stati Uniti d'America 2.493
SG - Singapore 484
IT - Italia 447
BR - Brasile 294
CN - Cina 222
DE - Germania 174
RU - Federazione Russa 168
BD - Bangladesh 139
HK - Hong Kong 113
SE - Svezia 109
VN - Vietnam 105
GB - Regno Unito 75
FR - Francia 67
IN - India 61
FI - Finlandia 52
ID - Indonesia 34
CI - Costa d'Avorio 23
AR - Argentina 22
TR - Turchia 22
CA - Canada 21
JP - Giappone 17
ZA - Sudafrica 17
NL - Olanda 16
MX - Messico 15
PL - Polonia 15
EC - Ecuador 14
IQ - Iraq 14
VE - Venezuela 13
CO - Colombia 11
BE - Belgio 9
CR - Costa Rica 9
UA - Ucraina 9
UZ - Uzbekistan 9
ES - Italia 8
PH - Filippine 7
AE - Emirati Arabi Uniti 6
NP - Nepal 6
SA - Arabia Saudita 6
TN - Tunisia 6
EG - Egitto 5
JO - Giordania 5
MA - Marocco 5
PK - Pakistan 5
AT - Austria 4
CH - Svizzera 4
HN - Honduras 4
LT - Lituania 4
LY - Libia 4
UY - Uruguay 4
AU - Australia 3
AZ - Azerbaigian 3
DO - Repubblica Dominicana 3
ET - Etiopia 3
KG - Kirghizistan 3
KR - Corea 3
LB - Libano 3
MY - Malesia 3
AL - Albania 2
CG - Congo 2
DZ - Algeria 2
GA - Gabon 2
HU - Ungheria 2
IE - Irlanda 2
KZ - Kazakistan 2
OM - Oman 2
SN - Senegal 2
SY - Repubblica araba siriana 2
TW - Taiwan 2
BB - Barbados 1
BG - Bulgaria 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BO - Bolivia 1
BY - Bielorussia 1
CZ - Repubblica Ceca 1
GE - Georgia 1
GN - Guinea 1
GY - Guiana 1
HR - Croazia 1
HT - Haiti 1
IL - Israele 1
IM - Isola di Man 1
IR - Iran 1
JM - Giamaica 1
LI - Liechtenstein 1
LV - Lettonia 1
MT - Malta 1
MU - Mauritius 1
NG - Nigeria 1
PT - Portogallo 1
PY - Paraguay 1
QA - Qatar 1
RO - Romania 1
SC - Seychelles 1
SR - Suriname 1
TH - Thailandia 1
TT - Trinidad e Tobago 1
Totale 5.451
Città #
Ashburn 370
Singapore 255
Fairfield 217
San Jose 158
Chandler 133
Houston 119
Hong Kong 111
Woodbridge 107
Milan 102
Beijing 96
Nyköping 86
Dallas 81
Council Bluffs 76
Cambridge 73
Bari 66
Seattle 66
Los Angeles 62
New York 61
Wilmington 60
Ann Arbor 58
Lauterbourg 42
Rome 39
Helsinki 36
Santa Clara 31
Ho Chi Minh City 30
Buffalo 26
Jakarta 26
Abidjan 23
Hanoi 23
Roxbury 23
Lawrence 21
São Paulo 21
Columbus 20
Inglewood 20
Boardman 18
Brooklyn 18
Jacksonville 18
Chennai 17
Des Moines 17
Falkenstein 17
Tokyo 17
Chicago 15
London 15
Moscow 15
San Diego 15
Frankfurt am Main 14
Munich 14
Nanjing 14
Atlanta 12
Warsaw 12
Figino 11
Salvador 11
Washington 11
Dong Ket 10
Phoenix 10
Poplar 10
Ankara 9
Brasília 9
Grottaglie 9
Paris 9
San José 9
Denver 8
Florence 8
Johannesburg 8
Nuremberg 8
Orem 8
Rio de Janeiro 8
Turku 8
Baghdad 7
Brussels 7
Curitiba 7
Guayaquil 7
Montreal 7
Princeton 7
Pune 7
Tashkent 7
Delhi 6
Montignoso 6
Naples 6
Stockholm 6
The Dalles 6
Turin 6
Wuhan 6
Amman 5
Charlotte 5
Jeddah 5
Manchester 5
Medellín 5
Mexico City 5
North Bergen 5
Salt Lake City 5
Sorocaba 5
Taranto 5
Amsterdam 4
Araraquara 4
Augusta 4
Boston 4
Caracas 4
Cerquilho 4
Changsha 4
Totale 3.326
Nome #
The analysis of myotonia congenita mutations discloses functional clusters of amino acids within CBS2 domain and C-terminal peptide of ClC-1 channel 290
ClC-1 chloride channels: state-of-the-art research and future challenges 231
Multidisciplinary study of a new ClC-1 mutation causing myotonia congenita: a paradigm to understand and treat ion channelopathies 215
Mapping ligand binding pockets in ClC-1 channels through an integrated in silico and experimental approach using anthracene-9-carboxylic acid and niflumic acid 212
Clinical, Molecular, and Functional Characterization of CLCN1 Mutations in Three Families with Recessive Myotonia Congenita 209
Pharmacogenetics of myotonic hNav1.4 sodium channel variants situated near the fast inactivation gate 206
ClC-1 mutations in myotonia congenita patients: insights into molecular gating mechanisms and genotype-phenotype correlation 195
Bioisosteric Modification of To042: Synthesis and Evaluation of Promising Use-Dependent Inhibitors of Voltage-Gated Sodium Channels 181
Coexistence of CLCN1 and SCN4A mutations in one family suffering from myotonia 170
Chaperone activity of niflumic acid on ClC-1 chloride channel mutants causing myotonia congenita 169
A novel KCNA1 mutation in a patient with paroxysmal ataxia, myokymia, painful contractures and metabolic dysfunctions 165
Safinamide's potential in treating nondystrophic myotonias: Inhibition of skeletal muscle voltage-gated sodium channels and skeletal muscle hyperexcitability in vitro and in vivo 165
Effects of Benzothiazolamines on Voltage-Gated Sodium Channels 156
Synthesis and Evaluation of Voltage-Gated Sodium Channel Blocking Pyrroline Derivatives Endowed with Both Antiarrhythmic and Antioxidant Activities 136
Emerging roles for ion channels in ovarian cancer: Pathomechanisms and pharmacological treatment 133
Increased sarcolemma chloride conductance as one of the mechanisms of action of carbonic anhydrase inhibitors in muscle excitability disorders 131
ECM Composition Differentially Regulates Intracellular and Extracellular pH in Normal and Cancer Pancreatic Duct Epithelial Cells 125
Functional characterization of ClC-1 mutations from patients affected by recessive myotonia congenita presenting with different clinical phenotypes. 124
Ion Channel Gene Mutations Causing Skeletal Muscle Disorders: Pathomechanisms and Opportunities for Therapy 118
Ion channels gene expression analysis in myotonia congenita patients carrying ClC-1 chloride channel mutations 117
Skeletal muscle ClC-1 chloride channels in health and diseases 116
Pathomechanisms of a CLCN1 Mutation Found in a Russian Family Suffering From Becker's Myotonia 115
Drug repurposing in skeletal muscle ion channelopathies 108
Ion Channel Involvement in Tumor Drug Resistance 108
Privileged scaffold-based design to identify a novel drug-like 5-HT7 receptor-preferring agonist to target Fragile X syndrome 105
Immersive and Non-Immersive Virtual Reality for Pain and Anxiety Management in Pediatric Patients with Hematological or Solid Cancer: A Systematic Review 103
Anti-Angiogenic Activity of Drugs in Multiple Myeloma 103
Targeted Therapies for Skeletal Muscle Ion Channelopathies: Systematic Review and Steps Towards Precision Medicine 102
Natural ClC-1 mutations causing myotonia congenita reduce sensitivity to 9-AC 98
Musculoskeletal Features without Ataxia Associated with a Novel de novo Mutation in KCNA1 Impairing the Voltage Sensitivity of Kv1.1 Channel 97
A c.1775C > T Point Mutation of Sodium Channel Alfa Subunit Gene (SCN4A) in a Three-Generation Sardinian Family with Sodium Channel Myotonia 96
Development of Riluzole Analogs with Improved Use-Dependent Inhibition of Skeletal Muscle Sodium Channels 91
Preclinical study of the antimyotonic efficacy of safinamide in the myotonic mouse model 90
Improvement of daratumumab- or elotuzumab-mediated NK cell activity by the bi-specific 4-1BB agonist, DARPin α-FAPx4-1BB: A preclinical study in multiple myeloma 89
Immunoglobulin Replacement Therapy: Insights into Multiple Myeloma Management 89
Pharmacological therapy of non-dystrophic myotonias 89
Coexistence of SCN4A and CLCN1 mutations in a family with atypical myotonic features: A clinical and functional study 88
Buprenorphine may be effective for treatment of paramyotonia congenita 88
Ion Channels in Multiple Myeloma: Pathogenic Role and Therapeutic Perspectives 83
Pleiotropic Effects of the NSAID Fenamates on Chloride Channels: Opportunity for Ion Channelopathies? 80
Uptake-Dependent and -Independent Effects of Fibroblasts-Derived Extracellular Vesicles on Bone Marrow Endothelial Cells from Patients with Multiple Myeloma: Therapeutic and Clinical Implications 74
Hunting for lubeluzole analogues as antimyotonic agents with reduced cardiac liability 73
NSAIDS AS MODULATORS OF CATION CHANNELS: FENAMATES REPURPOSING IN CHANNELOPATHIES 64
Target mutation-driven drug discovery 60
null 29
Totale 5.686
Categoria #
all - tutte 22.352
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 22.352


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022207 0 0 5 20 4 14 4 11 16 40 42 51
2022/2023356 35 54 33 17 24 52 11 54 46 9 14 7
2023/2024197 8 30 15 21 25 61 3 4 5 8 8 9
2024/20251.000 42 4 43 40 97 80 185 105 49 43 130 182
2025/20262.530 301 110 181 239 278 140 222 71 328 197 159 304
2026/2027208 61 93 54 0 0 0 0 0 0 0 0 0
Totale 5.686